NCT06925737 2026-03-13
MK-2400-001
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
5 trialsNCT05067140 2025-03-17
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
Novartis
Phase 1/2 Active not recruiting
NCT03050866 2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2 Unknown
NCT01393730 2018-03-15
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00006371 2012-09-27
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated